Abiopharma

Cidara Therapeutics to Participate in November Investor Conferences

Emergent BioSolutions Releases New Survey Findings Revealing Heightened Concerns About Biological Threats and U.S. Preparedness

Reviva to Present Negative Symptom Data for Brilaroxazine in Schizophrenia from the Phase 3 RECOVER Double-Blind and Open-Label Extension Trials at the CNS Summit 2025

Josh Ruben Joins PetVivo Holdings, Inc. Board of Directors

Cybin Announces $175 Million Registered Direct Offering

Edesa Biotech Reports Positive Results in Phase 3 Respiratory Study

BioNTech to Host Innovation Series R&D Day on November 11, 2025

BioNTech veranstaltet am 11. November 2025 „Innovation Series Day“ zu Forschung & Entwicklung

Accuray to Report First Quarter Fiscal 2026 Financial Results on November 5, 2025

Alto Neuroscience to Participate in Upcoming Investor Conferences